Mepolizumab
Dispensed in December 2025
Rolling 12 months
Net ingredient cost · December 2025
Figure 1. Mepolizumab: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to December 2025
Embed this chart
At a glance
- Therapeutic class Antihistamines, hyposensitisation and allergic emergencies
- Presentations 1 shown
- Average cost / item £3,360.00
Top presentations, December 2025
The individual products dispensed under Mepolizumab this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Nucala 100mg/1ml solution for injection pre-filled syringes | 0304020Y0BBABAB | 1 | £3,360 |
Source: NHSBSA Prescription Cost Analysis · to December 2025 OGL v3.0
Where Mepolizumab is dispensed
The regions and dispensing practices with the highest Mepolizumab volumes.
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
In NHS hospitals
Mepolizumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.
Compare Mepolizumab with
Other medicines in the same BNF section, by prescribing volume.